Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

(S)-3-(1-(9H-purin-6-ylamino)ethyl)-8-chloro-2-phenylisoquinolin-1(2H)-one

EU orphan designation number: EU/3/13/1125   
Active ingredient: (S)-3-(1-(9H-purin-6-ylamino)ethyl)-8-chloro-2-phenylisoquinolin-1(2H)-one
Indication: Treatment of chronic lymphocytic leukaemia/small lymphocytic lymphoma
Sponsor: Voisin Consulting S.A.R.L.
3 rue des Longs Prés, F-92100 Boulogne-Billancourt, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
30/04/2013 Orphan designation EMA/OD/196/12 (2013)2562 of 26/04/2013
13/11/2015 Transfer of orphan designation EMA/OD/196/12/T/01 (2015)8036 of 11/11/2015
17/03/2016 Corrigendum (2016)1716 of 15/03/2016
28/09/2016 Transfer of orphan designation EMA/OD/196/12/T/02 (2016) 6308 of 26/09/2016